EUVIMEDEUVIMED entdecken
Crossref

Cytogenetic Characteristics and Treatment Outcomes of Congenital Acute Leukemia in Children in Kazakhstan: Retrospective Study

Saule Nukusheva, Almagul Saduova, Aman Berkinbay, Samal Aliyeva, Dana Zauytbek, Akerke Azanbai, Aygerim Ayazova, Araylym Abduali, Aiya Slamkhan, Anel Daber

Journal of Clinical Medicine of Kazakhstan · 08.04.2026 · 23 (2) · 51-56

DOI: 10.23950/jcmk/18326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine of Kazakhstan, erschienen am 08.04.2026. Verfasst von Saule Nukusheva und 9 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Congenital acute leukemia (CAL) is a rare and aggressive hematologic malignancy diagnosed within the first 28 days of life. Cytogenetic abnormalities are essential for risk stratification and prognosis, but data on CAL in Kazakhstan remain limited.

Objective

To describe cytogenetic characteristics and evaluate their association with treatment outcomes in children with congenital and early infant acute leukemia treated at a tertiary pediatric center in Kazakhstan.

Methods

This retrospective single-center study included 33 children treated between 2018 and 2023 at the Scientific Center of Pediatrics and Pediatric Surgery (Almaty, Kazakhstan). Patients were classified as true CAL (diagnosis ≤28 days) or early infant leukemia (>28 days). Cytogenetic findings, treatment protocols, remission, relapse, mortality, treatment-related toxicity, and survival were analyzed. Overall survival (OS) and event-free survival (EFS) were assessed using the Kaplan–Meier method.

Results

Cytogenetic abnormalities were detected in 17/33 patients (51.5%). Favorable abnormalities included t(12;21), t(8;21), and inv(16), whereas unfavorable abnormalities included t(4;11)/KMT2A-rearranged leukemia and t(9;22). Complete remission after induction was achieved in 66.7% of patients and was significantly more frequent in the favorable cytogenetic group than in the unfavorable group (91.6% vs. 58.3%; p = 0.019). Treatment-related toxicity occurred in 42.4% of patients and was more common among those with non-complete remission (83.3% vs. 31.8%; p = 0.017). Estimated 2-year OS was 83.3% in the favorable cytogenetic group and 50.0% in the unfavorable group, while estimated 2-year EFS was 75.0% and 41.7%, respectively. Survival differed significantly according to cytogenetic risk (log-rank p = 0.032 for OS; p = 0.021 for EFS).

Conclusion

Congenital and early infant acute leukemia in this single-center cohort from Kazakhstan demonstrated substantial cytogenetic heterogeneity associated with remission and survival outcomes. Cytogenetic-based risk stratification and careful management of treatment-related toxicity may improve outcomes in this vulnerable patient population.

Zitieren

APA

Nukusheva, S., Saduova, A., Berkinbay, A., Aliyeva, S., Zauytbek, D., Azanbai, A., Ayazova, A., Abduali, A., Slamkhan, A., & Daber, A. (2026). Cytogenetic Characteristics and Treatment Outcomes of Congenital Acute Leukemia in Children in Kazakhstan: Retrospective Study. Journal of Clinical Medicine of Kazakhstan, 23(2), 51-56. https://doi.org/10.23950/jcmk/18326

Vancouver

Nukusheva S, Saduova A, Berkinbay A, Aliyeva S, Zauytbek D, Azanbai A, et al. Cytogenetic Characteristics and Treatment Outcomes of Congenital Acute Leukemia in Children in Kazakhstan: Retrospective Study. Journal of Clinical Medicine of Kazakhstan. 2026;23(2):51-56. doi:10.23950/jcmk/18326

BibTeX
@article{Nukusheva2026,
  author = {Nukusheva, Saule and Saduova, Almagul and Berkinbay, Aman and Aliyeva, Samal and Zauytbek, Dana and Azanbai, Akerke and Ayazova, Aygerim and Abduali, Araylym and Slamkhan, Aiya and Daber, Anel},
  title = {Cytogenetic Characteristics and Treatment Outcomes of Congenital Acute Leukemia in Children in Kazakhstan: Retrospective Study},
  journal = {Journal of Clinical Medicine of Kazakhstan},
  year = {2026},
  volume = {23},
  number = {2},
  pages = {51--56},
  doi = {10.23950/jcmk/18326}
}
Kostenlos starten →